介入性肿瘤学全球市场规模、份额、成长分析，按产品类型、癌症类型、手术、地区 - 产业预测，2024-2031 年

2022年全球介入性肿瘤市场规模为21.7亿美元，从2023年的23.1亿美元成长到2031年的39.2亿美元，预计在预测期间（2024年-2031年）将以复合年增长率成长。 。

介入性肿瘤学的全球市场细分是更广泛的癌症领域中快速成长的领域，主要由微创癌症治疗的进步所推动。此专业使用切除、栓塞和放射治疗等影像导引手术来治疗癌性肿瘤。全球癌症发生率不断上升，加上对微创治疗方案的需求不断增加，正在推动市场发展。随着越来越多的患者和医疗保健提供者选择介入肿瘤学领域的治疗而不是传统手术，该市场正在经历显着增长。更好的成像技术和更精确的仪器等技术创新使这些治疗更加有效。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价值链分析
• 价格分析

全球介入性肿瘤学市场：按产品

• 市场概况
• 栓塞装置
  • 放射栓塞剂
  • 非放射性栓塞剂
  • 微球
  • 涂层珠
  • 细颗粒
• 消融装置
  • 射频 (RF) 消融装置
  • 微波消融装置
  • 冷冻消融装置
  • 其他消融装置
• 支撑装置

介入肿瘤学的全球市场：按癌症类型

• 市场概况
• 肝癌
• 肾癌
• 乳癌
• 肺癌
• 骨癌
• 摄护腺癌
• 其他癌症

介入肿瘤学的全球市场：按程序

• 市场概况
• 经导管动脉放射栓塞/选择性体内放射疗法（Tare/Sirt）
• 经导管动脉化疗栓塞术（TACE）
• 肿瘤热消融术
• 经导管动脉栓塞/品牌栓塞（TAE）
• 非热肿瘤消融

全球介入性肿瘤学市场：依最终用户分类

• 市场概况
• 医院
• 门诊手术中心
• 研究/学术机构

全球介入性肿瘤学市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Boston Scientific Corporation
• Medtronic Plc（Ireland）
• Johnson & Johnson（US）
• Terumo Corporation（Japan）
• Merit Medical Systems, Inc.（US）
• Teleflex, Inc.（US）
• Angiodynamics, Inc.（US）
• Becton, Dickinson And Company（US）
• Healthtronics, Inc.（US）
• Trod Medical（Belgium）
• Sanarus Technologies, Inc.（US）
• Imbiotechnologies Ltd.（Canada）
• Medwaves, Inc.（US）
• Icecure Medical（Israel）
• Cook Medical（US）
• Profound Medical Corp.（Canada）
• Sirtex Medical（Australia）
• Baylis Medical Company, Inc.（Canada）
• Accuray（US）
• Alpinion Medical Systems（South Korea）

Global Interventional Oncology Market size was valued at USD 2.17 billion in 2022 and is poised to grow from USD 2.31 billion in 2023 to USD 3.92 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Interventional Oncology Market is a rapidly growing segment within the broader oncology landscape, primarily driven by advancements in minimally invasive cancer treatments. This specialized field involves the use of image-guided procedures such as ablation, embolization, and radiotherapy to treat cancerous tumors. The rising global cancer burden, coupled with the increasing demand for less invasive treatment options, is pushing the market forward. As more patients and healthcare providers opt for interventional oncology procedures over traditional surgery, the market is witnessing significant growth. Technological innovations, such as better imaging techniques and more precise instruments, are further enhancing the effectiveness of these treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Interventional Oncology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Interventional Oncology Market Segmental Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Interventional Oncology Market

One of the primary drivers of the interventional oncology market is the rising global prevalence of cancer. With an aging population and increasing exposure to risk factors like tobacco use, obesity, and environmental pollutants, cancer rates continue to soar worldwide. According to the World Health Organization (WHO), there are over 19 million new cancer cases annually, leading to increased demand for advanced treatment options like interventional oncology. This method offers a minimally invasive alternative to traditional surgeries, making it more appealing for patients with inoperable or metastatic tumors. Additionally, as survival rates improve with early diagnosis, more patients are opting for less invasive procedures. This rise in cancer cases, along with the growing awareness of interventional oncology's benefits, is accelerating the market's growth trajectory.

Restraints in the Interventional Oncology Market

A significant restraint for the interventional oncology market is the high cost of treatment, particularly in developing regions. Although the procedures are minimally invasive and often more patient-friendly, the technologies and devices used-such as advanced imaging systems and specialized instruments-are expensive. The costs associated with training healthcare professionals and maintaining high-quality equipment further increase the financial burden. In regions with underdeveloped healthcare infrastructure, the adoption of interventional oncology is slower due to these high costs. Moreover, the lack of reimbursement policies for such advanced treatments in many countries further limits their accessibility, hampering market growth in cost-sensitive regions.

Market Trends of the Interventional Oncology Market

A prominent trend in the interventional oncology market is the growing use of image-guided therapies. Technologies like computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound are being integrated into oncology treatments to offer more precision in targeting tumors. These image-guided procedures allow for real-time visualization, reducing the chances of damaging healthy tissues and improving treatment outcomes. The use of robotic-assisted systems for these therapies is also on the rise, as they offer higher accuracy and reduced recovery times. This trend is expected to continue as advancements in imaging technology make these procedures safer, more effective, and accessible to a broader patient population.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis

Interventional Oncology Market, By Product

• Market Overview
• Embolization Devices
  • Radioembolic Agents
  • Non-Radioactive Embolic Agents
  • Microspheres
  • Coated Beads
  • Microparticles
• Ablation Devices
  • Radiofrequency (Rf) Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices
• Support Devices

Interventional Oncology Market, By Cancer Type

• Market Overview
• Liver Cancer
• Kidney Cancer
• Breast Cancer
• Lung Cancer
• Bone Cancer
• Prostate Cancer
• Other Cancers

Interventional Oncology Market, By Procedure

• Market Overview
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (Tare/Sirt)
• Transcatheter Arterial Chemoembolization (Tace)
• Thermal Tumor Ablation
• Transcatheter Arterial Embolization/Bland Embolization (Tae)
• Non-Thermal Tumor Ablation

Interventional Oncology Market, By End User

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Research & Academic Institutes

Interventional Oncology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angiodynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson And Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healthtronics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trod Medical (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanarus Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imbiotechnologies Ltd. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medwaves, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icecure Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profound Medical Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baylis Medical Company, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpinion Medical Systems (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments